KD

Kevin D. Burris

Quantitative Biology, Eli Lilly and Company

Affiliated withEli Lilly and Company

Research Area

Biography

Kevin D. Burris has not added Biography.
If you are Kevin D. Burris and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2014

Other Publications

Article	Year
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 12065741	2002
(+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist. Journal of medicinal chemistry\| PubMed ID: 12166939	2002
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. European journal of pharmacology\| PubMed ID: 12860477	2003
2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy. Bioorganic & medicinal chemistry letters\| PubMed ID: 14592493	2003
Synthesis and SAR exploration of dinapsoline analogues. Bioorganic & medicinal chemistry\| PubMed ID: 14759732	2004
The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release. Brain research\| PubMed ID: 15019558	2004
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. Journal of psychopharmacology (Oxford, England)\| PubMed ID: 15358981	2004
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. European journal of pharmacology\| PubMed ID: 15894311	2005
Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists. Bioorganic & medicinal chemistry letters\| PubMed ID: 15990298	2005
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology\| PubMed ID: 17242925	2007
Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorganic & medicinal chemistry letters\| PubMed ID: 20036536	2010
Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of corticotropin-releasing factor type 1 receptor (CRF1R). Bioorganic & medicinal chemistry letters\| PubMed ID: 20185312	2010

Copyright © 2026 MyJoVE Corporation. All rights reserved.